| 摘要 |
Novel potentiating steroid carbamates having the general formula (I) ST-OCONR1R2(I) wherein ST is a steroid or steroid derivative, of the structure (II) optionally containing double bonds and additional oxygen substituents; the carbamate moiety OCONR1R2 has lipophilic properties and is selected from N,N-dibutylcarbamate, N-(3-morpholin-4-yl-propyl)-carbamate, 4-benzyl-piperazine-1-carboxylic acid ester, N-(3-dibutylamino-propyl)-carbamate, N,N-dipropyl-carbamate, N-hexyl-carbamate, N-(1-benzyl-piperidine-4-yl)-carbamate, N-cyclohexylmethyl-carbamate, N-butyl-N-ethyl-carbamate, N-benzyl-carbamate, N-(3-dibenzazepin-1-yl-propyl)-N-methyl-carbamate, N-naphtalen-1-yl-methyl-carbamate, N-diphenylmethyl-carbamate, N,N-dibenzyl-carbamate, 3,4-dihydro-1H-isoquinoline-2-carboxylic acid ester, N,N-dipentyl-carbamate, N,N-diisobutyl-carbamate and N,N-bis-(4-fluoro-benzyl)-carbamate; and pharmaceutically acceptable salts thereof, in combination with radiation therapy and one or more cytotoxic drugs, optionally together with a pharmaceutically acceptable carrier and, if desired, other pharmacologically acceptable agents. |
